CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells.
CXCL12 and its receptor CXCR4 play an important role in hematopoietic stem/progenitor cell (HSPC) migration from and retention within the bone marrow. HSPCs are very selective in their chemotactic response and undergo chemotaxis only in response to CXCL12. In addition to CXCR4, HSPCs express receptors for various other chemokines; however, the role of these receptors is not well understood. Freshly isolated CD34(+) cells (highly enriched for HSPCs) from cord blood (CB) express low levels of CCR5; however, if the cells were washed with acidic buffer before Ab staining to remove any ligand bound to CCR5, then nearly 80% of CD34(+) CB cells were found to express CCR5 on the cell surface. Although none of the CCR5 ligands investigated in this study (CCL3, CCL4, and CCL5) induced chemotaxis, at relatively high concentrations they transiently enhanced CXCL12-mediated chemotaxis of CD34(+) CB cells. In contrast, CXCL12-mediated adhesion of cells to VCAM-1-coated surfaces was reduced if CD34(+) CB cells were pretreated with these CCR5 ligands for 15 min. The effect of these chemokines on CXCL12-mediated responses was not at the level of CXCR4 expression, but on downstream signaling pathways elicited by CXCL12. Pretreatment with CCR5 chemokines enhanced CXCL12-mediated Akt phosphorylation, but down-modulated calcium flux in CD34(+) CB cells. Modulation of CXCL12-mediated responses of CD34(+) cells by CCR5 chemokines provides a possible mechanism that underlies movement of HSPCs during inflammation.
Basu
Sunanda
S
Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Research Institute No. 2 Building, Room 302, 950 West Walnut Street, Indianapolis, IN 46202, USA. sunbasu@iupui.edu
Broxmeyer
Hal E
HE
D018952:Antigens, CD34 / Q000096:biosynthesis / Q000276:immunology; D015153:Blotting, Western; D002448:Cell Adhesion / Q000502:physiology; D054405:Chemokine CCL3 / Q000276:immunology / Q000378:metabolism; D054407:Chemokine CCL4 / Q000276:immunology / Q000378:metabolism; D018946:Chemokine CCL5 / Q000276:immunology / Q000378:metabolism; D054377:Chemokine CXCL12 / Q000276:immunology / Q000378:metabolism*; D002634:Chemotaxis, Leukocyte / Q000502:physiology*; D005312:Fetal Blood / Q000276:immunology / Q000378:metabolism; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000276:immunology / Q000378:metabolism*; D019713:Receptors, CCR5 / Q000276:immunology / Q000378:metabolism*; D015398:Signal Transduction / Q000276:immunology
D018952:Antigens, CD34; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D018946:Chemokine CCL5; D054377:Chemokine CXCL12; D008024:Ligands; D019713:Receptors, CCR5; D051057:Proto-Oncogene Proteins c-akt